Kymera Therapeutics, Inc.
2020 Q4 - 2025 Q4 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 10,607 | 0.0% | 135,894 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 6,640 | 0.0% | 152,165 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 3,903 | 0.0% | 142,587 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 5,926 | 0.0% | 147,296 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 6,071 | 0.0% | 128,267 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 3,883 | 0.0% | 130,077 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 4,613 | 0.0% | 114,757 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 2,548 | 0.0% | 100,073 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 1,070 | 0.0% | 76,980 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 1,871 | 0.0% | 81,390 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,250 | 0.0% | 75,941 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 1,656 | 0.0% | 64,986 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 1,432 | 0.0% | 65,109 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 1,326 | 0.0% | 65,825 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 2,561 | 0.0% | 61,413 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 1,120 | 0.0% | 17,739 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 1,017 | 0.0% | 17,316 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 784 | 0.0% | 16,165 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 238 | 0.0% | 6,114 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 376 | 0.0% | 6,065 | 12/31/2020 |